KYMR
Kymera Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$79.03
+1.53 ▲ +1.97%
🌙 3월 13일 4:52 PM ET (한국 3/14 05:52)
$79.03
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -3.68 | Insider Own | 14.4% | Shs Outstand | 0.08B | Perf Week | -5.34% |
| Market Cap | 6.45B | Forward P/E | - | EPS next Y | -11.54% | Insider Trans | 11.11% | Shs Float | 0.07B | Perf Month | -3.94% |
| Enterprise Value | 5.69B | PEG | - | EPS next Q | -0.87 | Inst Own | 98.05% | Short Float | 14.7% | Perf Quarter | -12.08% |
| Income | -0.31B | P/S | 164.55 | EPS this Y | 1.59% | Inst Trans | 8.12% | Short Ratio | 12.83 | Perf Half Y | 71.06% |
| Sales | 0.04B | P/B | 4.07 | EPS next 5Y | -3.46% | ROA | -22.89% | Short Interest | 10.28M | Perf YTD | 1.57% |
| Book/sh | 19.42 | P/C | 7.61 | EPS past 3/5Y | -8.68% -3.19% | ROE | -25.78% | 52W High | -23.27% ($103.00) | Perf Year | 136.26% |
| Cash/sh | 10.39 | P/FCF | - | Sales past 3/5Y | -5.74% 2.87% | ROIC | -18.89% | 52W Low | 306.43% ($19.44) | Perf 3Y | 153.22% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -24% | Gross Margin | 78.8% | Volatility(W/M) | 4.59% 5.45% | Perf 5Y | 40.87% |
| Dividend TTM | - | EV/Sales | 145.02 | Sales Y/Y TTM | -16.7% | Oper. Margin | -881.27% | ATR (14) | 4.42 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 10.47 | EPS Q/Q | -9.37% | Profit Margin | -794.06% | RSI (14) | 42 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.47 | Sales Q/Q | -61.18% | SMA20 | -8.1% ($86) | Beta | 2.33 | Target Price | $119.71 |
| Payout | - | Debt/Eq | 0.05 | Earnings | 2000000 | SMA50 | -0.2% ($79.19) | Rel Volume | 0.52 | Prev Close | $77.5 |
| Employees | 238 | LT Debt/Eq | 0.04 | EPS/Sales Surpr. | -23.77% -80.92% | SMA200 | 30.61% ($60.51) | Avg Volume(3M) | 0.80M | Price | $79.03 |
| IPO | 2020/8/21 | Option/Short | Yes/Yes | Trades | 7082 | Volume | 417,168 | Change | 1.97% |
뉴스 로딩 중...